In contrast to β1- and β2ARs, cardiac β3AR expression increases in chronic ischemia and heart failure, which is considered a counterregulatory mechanism to prevent chronic adrenergic overactivation [21,56,58,59,60]. The gene discussed is ADRB3; the disease is heart failure.